Showing 441 - 460 results of 8,153 for search '"tumors"', query time: 0.11s Refine Results
  1. 441

    Dilated SE-DenseNet for brain tumor MRI classification by Yuannong Mao, Jiwook Kim, Lena Podina, Mohammad Kohandel

    Published 2025-01-01
    “…This novel approach aims to improve upon state-of-the-art methods of tumor identification. Our model, trained and evaluated on a comprehensive Kaggle brain tumor dataset, demonstrated superior performance over established convolution-based and transformer-based models: ResNet-101, VGG-19, original DenseNet-121, MobileNet-V2, ViT-L/16, and Swin-B across key metrics: F1-score, accuracy, precision, and recall. …”
    Get full text
    Article
  2. 442
  3. 443
  4. 444

    Adrenal Incidentalomas: Should We Operate on Small Tumors in the Era of Laparoscopy? by Michał Pędziwiatr, Michał Natkaniec, Mikhail Kisialeuski, Piotr Major, Maciej Matłok, Damian Kołodziej, Anna Zub-Pokrowiecka, Piotr Budzyński, Andrzej Budzyński

    Published 2014-01-01
    “…Tumor size smaller than 4 cm as an indication for surgical treatment of incidentaloma is still a subject of discussion. …”
    Get full text
    Article
  5. 445
  6. 446

    Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors by Estela Regina Ramos Figueira, Julia Fray Ribeiro, Thiago Costa Ribeiro, Ricardo Jureidini, Guilherme Naccache Namur, Thiago Nogueira Costa, Telesforo Bacchella, Ivan Cecconello

    Published 2021-01-01
    “…The incidence of small nonfunctioning neuroendocrine pancreatic tumors (NF-PNETs) has been increasing systematically in the last few decades. …”
    Get full text
    Article
  7. 447

    Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects by Yelei Guo, Yao Wang, Weidong Han

    Published 2016-01-01
    “…Many studies have struggled to improve the clinical responses to and benefits of CART-cell treatment of solid tumors. In this review, the status quo of CART cells and their clinical applications for solid tumors will be summarized first. …”
    Get full text
    Article
  8. 448
  9. 449

    Clinical Applicability of Various Treatment Approaches for Upper Gastrointestinal Submucosal Tumors by Jing Zhang, Kaili Huang, Shigang Ding, Ye Wang, Te Nai, Yonghui Huang, Liya Zhou

    Published 2016-01-01
    “…Submucosal tumor (SMT) is a disease that is commonly discovered during endoscopic examination. …”
    Get full text
    Article
  10. 450

    The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors by Lucia D’Amico, Ilaria Roato

    Published 2015-01-01
    “…Bone metastases are frequent and debilitating consequence for many tumors, such as breast, lung, prostate, and kidney cancer. …”
    Get full text
    Article
  11. 451
  12. 452

    Improvement in Automated Diagnosis of Soft Tissues Tumors Using Machine Learning by El Arbi Abdellaoui Alaoui, Stéphane Cédric Koumetio Tekouabou, Sri Hartini, Zuherman Rustam, Hassan Silkan, Said Agoujil

    Published 2021-03-01
    “…Soft Tissue Tumors (STT) are a form of sarcoma found in tissues that connect, support, and surround body structures. …”
    Get full text
    Article
  13. 453
  14. 454

    Treatment of Liver Metastases in Patients with Neuroendocrine Tumors of Gastroesophageal and Pancreatic Origin by Ping Gu, Jennifer Wu, Elliot Newman, Franco Muggia

    Published 2012-01-01
    “…Well-to-moderately differentiated neuroendocrine tumors of gastroesophageal and pancreatic origin (GEP-NETs) with liver metastasis are a heterogeneous group of malignancies for which a range of therapeutic options have been employed. …”
    Get full text
    Article
  15. 455

    Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation by Ilenia Bartolini, Lapo Bencini, Matteo Risaliti, Maria Novella Ringressi, Luca Moraldi, Antonio Taddei

    Published 2018-01-01
    “…Incidental diagnosis of pancreatic neuroendocrine tumors (PanNETs) greatly increased in the last years. …”
    Get full text
    Article
  16. 456

    Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer by Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki

    Published 2015-01-01
    “…New drugs for gynecologic tumors may be found by drug repositioning. For example, PPAR ligands may be effective against ovarian cancer, since PPAR activation eliminates COX-2 expression, arrests the cell cycle, and induces apoptosis. …”
    Get full text
    Article
  17. 457

    Different DNA Loidy Patterns for the Differentiation of Common Subtypes of Renal Tumors by Guorong Li, Michèle Cottier, Odile Sabido, Anne Gentil-Perret, Claude Lambert, Christian Genin, Jacques Tostain

    Published 2005-01-01
    “…Objectives: The common subtypes of renal tumors are conventional or clear cell carcinoma, papillary carcinoma, chromophobe carcinoma and oncocytoma. …”
    Get full text
    Article
  18. 458
  19. 459

    A Radiograph Dataset for the Classification, Localization, and Segmentation of Primary Bone Tumors by Shunhan Yao, Yuanxiang Huang, Xiaoyu Wang, Yiwen Zhang, Ian Costa Paixao, Zhikang Wang, Charla Lu Chai, Hongtao Wang, Dinggui Lu, Geoffrey I Webb, Shanshan Li, Yuming Guo, Qingfeng Chen, Jiangning Song

    Published 2025-01-01
    “…Abstract Primary malignant bone tumors are the third highest cause of cancer-related mortality among patients under the age of 20. …”
    Get full text
    Article
  20. 460

    CLINICAL AND RADIOLOGICAL PARAMETERS IN MALIGNANT SPINAL TUMORS: A DESCRIPTIVE ANALYSIS by Marcelo Diniz de Menezes, Mariana Demétrio de Sousa Pontes, Carlos Fernando Pereira da Silva Herrero

    Published 2025-02-01
    “…Clinical evaluation included age, sex, tumor lesions, treatments, surgical procedures, and complications. …”
    Get full text
    Article